Cancer BiologybioRxivPreprint
Tumor-specific EphA2 receptor tyrosine kinase inhibits anti-tumor immunity by recruiting suppressive myeloid populations in NSCLC
E. F. Shiuan, W. Song, S. Wang…·J. Chen
This study shows that EphA2 overexpression in NSCLC tumors reduces T cell infiltration and increases myeloid suppressor cells, promoting immune evasion.
DOI 10.1101/2020.05.08.084830